Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

98.20
Delayed Data
As of Aug 27
 +0.91 / +0.94%
Today’s Change
21.84
Today|||52-Week Range
110.68
+158.01%
Year-to-Date

Today’s Trading

Previous close97.29
Today’s open99.02
Day’s range96.84 - 100.00
Volume624,389
Average volume (3 months)768,138
Market cap$4.1B
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)+1,372.22%
Earnings growth (this year)-73.54%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+25.41%
P/E ratio34.7
Price/Sales13.32
Price/Book13.92

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.67-1.16%
MRMindray Medical Inte...+0.33+1.35%
NUVANuVasive Inc+1.03+1.99%
GMEDGlobus Medical Inc+0.27+1.09%
Data as of 08/27/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)$0.14
Annual revenue (last year)$230.3M
Annual profit (last year)$113.7M
Net profit margin49.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers